This inventor holds 2 USPTO granted patents. Top assignee: Vion Pharmaceuticals, Inc.. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-1999
Title: Innovations of Inventor Jun Li
Introduction
Jun Li is a notable inventor based in Hamden, CT, who has made significant contributions to the field of pharmaceuticals. He holds two patents that focus on the synthesis of ribonucleotide reductase inhibitors, which are crucial in cancer treatment.
Latest Patents
His latest patents include a process for the synthesis of ribonucleotide reductase inhibitors 3-AP. This invention relates to improved and efficient chemical syntheses of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and 3-amino-4-methylpyridine-2-carboxaldehyde thiosemicarbazone (3-AMP). Another significant patent is for prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP. This invention introduces novel prodrug forms that exhibit increased water solubility, bioavailability, and resistance to in vivo acetylation of their amino functions.
Career Highlights
Jun Li is currently associated with Vion Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing compounds that can enhance the efficacy of cancer treatments.
Collaborations
He has collaborated with notable colleagues such as Xiuyan Li and Terrence W Doyle, contributing to advancements in their shared field of research.
Conclusion
Jun Li's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile